Baroda BNP Paribas Health And Wellness Fund · Regular · Growth
Baroda BNP Paribas Mutual Fund
NAV
₹10.9805
as of 17 Nov 2026
Expense Ratio
2.70%
AUM
₹511 Cr
Lumpsum returns (CAGR)
- 1Y
- +13.52%
- 3Y
- —
- 5Y
- —
- Since Inception
- +6.96%
SIP returns (XIRR)
- 1Y
- +21.33%
- 3Y
- —
- 5Y
- —
- Since Inception
- +15.21%
Not enough verified history to show honest backtest scenarios (this fund is under 3 years old).
Risk Metrics
Trailing 1 year, annualised0.11
Sharpe Ratio
+0.04
Alpha
0.57
Beta
0.11
Sortino
11.96%
Std Dev
-11.93%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology72.78%
- Healthcare Services20.73%
- Insurance2.63%
- IT - Services0.89%
Each sector links to the mutual funds most exposed to it.
Related reading
Thinking about Baroda BNP Paribas Health And Wellness Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Limited8.58%
- 2Divi'S Laboratories Limited8.41%
- 3Torrent Pharmaceuticals Limited7.74%
- 4Laurus Labs Limited7.56%
- 5Ipca Laboratories Limited6.06%
- 6Lupin Limited5.86%
- 7Apollo Hospitals Enterprise Limited5.58%
- 8Fortis Healthcare Limited4.06%
- 9Glenmark Pharmaceuticals Limited3.13%
- 10Aurobindo Pharma Limited2.89%
What this fund does
Baroda BNP Paribas Health And Wellness Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Baroda BNP Paribas Health And Wellness Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Baroda BNP Paribas Mutual Fund. The fund has been operational for over 1 years. It manages assets worth ₹511 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.70%.